Plasma cell tumors are characterized by a monoclonal proliferation of immunoglobulin-secreting plasma cells. Dural infiltration of plasma cells without involvement of the parenchyma, leptomeninges or skull is a rare event. We present a 34-year-old man presenting with hallucination and amnesia. Magnetic resonance imaging revealed a left fronto-temporal mass with a dural tail mimicking meningioma. The mass was excised and histopathological examination revealed sheet of mature plasma cells. The cells were immunoreactive for kappa light chain, MUM1, CD38, and negative for epithelial membrane antigen. There was no recurrence after postoperative radiotherapy. Intracranial involvement from plasmacytoma should be considered in a case of solitary dural mass.
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Dural Plasmacytoma mimicking meningioma

Menenjiyomu Taklit Eden Dural Plazmositom
INTRoduCTIoN
Plasma cell tumors are characterized by a monoclonal proliferation of plasma cells. Plasmacytoma may arise from osseous (intramedullary) or non-osseous (extramedullary) sites, may be solitary or multiple, and may be associated with or may progress to multiple myeloma. Intracranial plasmacytoma can arise from the cranium, meninges or brain parenchyma (7, 9) . Diffuse leptomeningeal and/ or parenchymal involvement are seen in multiple myeloma. Dural infiltration without skull or brain parenchyma involvement is an extremely rare event (1, 4, 5) . The differential diagnosis of plasmacytoma in dura mater includes meningioma, which has a similar MRI appearance, metastasis and lymphoma of the dura mater. Meningioma is the most common primary nonglial brain tumor with typical radiological features: an extraaxial tumor with broad attachment to the dura, hyperdense on computerized tomography (CT), isointense with grey matter on T1-weighted MRI with enhancing 'dural tail' (1, 5, 6) .
CASE REPoRT
In October 2011, a 34-year-old man presented at our Neurosurgery Department with a 6-month history of hallucination and amnesia. On magnetic resonance imaging (MRI), an extra-parenchymal mass in the left fronto-temporal region with a broad dural base was revealed, strongly suggestive of a meningioma. It was a solitary lesion without associated lytic lesions in the skull (Figure 1 ). He underwent surgery via a left frontal craniotomy and the tumor was excised.
On histological examination, the cellular tumor was composed of mature plasma cells with eccentric nuclei, a paranuclear clear area and coarse chromatin was mixed with immature plasma cells. The immature plasma cells exhibited binucleation and large nucleoli.
Typical histological features of meningioma such as whorls or nuclear pseudo inclusions were absent (Figure 2A,B) . Therefore, rhabdoid meningioma vs. plasmacytoma was considered in the differential diagnosis. The cells were positive for CD38 ( Figure 3 ) and MUM1 and expressed kappa light chain, but were negative for lambda light chain, epithelial membrane antigen (EMA), cytokeratin, vimentin and myeloperoxidase (MPO), (DAKO, Denmark). These findings are indicative of neoplastic plasma cells. CD38 and MUM1 are markers of neoplastic plasma cells. EMA is considered as an arachnoidal cels marker, expressed by most meningiomas in diffuse fashion. After the diagnosis of meningeal plasmacytoma, a systematic work up to rule out multiple myeloma was performed. No additional sites of tumoral lesion were identified on either computed tomography or bone scan. Bone marrow aspiration and biopsy showed a normocellular marrow. Serum immunoglobulin levels were normal (IgG 1,28 mg/dL, IgA 397 mg/dL, IgM 52g/ dL, and IgE 79 IU/mL). Serum protein immunoelectrophoresis showed a normal pattern. Urine Bence-Jones protein was negative. Hypercalcemia was not detected. Thus, a diagnosis of extramedullary plasmacytoma was made. He underwent local external beam radiotherapy at a dose of 50 Gy, which resulted in the disappearance of the remaining tumor and there has been no recurrence. 
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immunoglobulin. Primary extramedullary plasmacytomas are uncommon tumors, mainly arising in the head and neck region, particularly the upper aerodigestive tract. Conversion to multiple myeloma more frequently occurs in intramedullary plasmacytoma. Overall, cranial and intracranial plasmacytoma may involve the cranial vault and the skull base or the brain parenchyma. However, intracranial involvement in plasmacytoma is uncommon (9,10).
Cerase et al., reviewed the clinical features and neuroradiological findings of seven patients diagnosed as plasmacytoma and multiple myeloma with intracranial growth (3). They believed that intracranial involvement in multiple myeloma generally results from extramedullary tumor masses arising from bone lesions in the calvaria, skull base, and nasal or paranasal sinuses. Dural involvement usually resulted from direct spread of contiguous bone lesions. Leptomeningeal spread of multiple myeloma was also occurred by hematogenous rout as focal, multifocal or diffuse forms (3). Sahin et al., reported a case of dural plasmacytoma in a patient with multiple myeloma, who presented with headache four years after complete remission of disease (8). Manabe et al., described a 59-yearold man presented with history of amnesia. The temporal mass was plasmacytoma and no additional sites were identified. The patient underwent external beam radiotherapy to the brain at a dosage of 50 Gy, which resulted in complete disappearance of the mass (6). Vujovic el al., reported another case of intracranial plasmacytoma arising from the meninges, which was treated with surgery and radiotherapy (11) .
Solitary dural plasmacytoma is rare and mostly occurs in the fifth decade of life with female predominance. Increased intracranial pressure and seizure are the usual clinical presentation. There is no pathognomonic radiologic feature. The differential diagnosis in such cases includes meningioma and metastasis. On CT scan, an intracranial plasmacytom usually presents as a dense tumor with enhancement after intravenous contrast administration. A sharp tumor border with lack of bony sclerosis is suggestive of solitary plasmacytoma. Metastatic tumors (most commonly from thyroid, renal, or bronchial cancers) are usually lytic lesions (3, 5, 6) . However, metastatic disease should be considered in all patients who experience new neurological finding, even after a prolonged disease-free interval (3).
The clinical and neuroradiological spectrum of intracranial plasmacytoma and multiple myeloma is very different. Therefore they must be taken into account in cranial osseous and dural lesions (3, 8) . Definite distinction may be impossible and requires histopathological examination. To make the correct diagnosis, systemic multiple myeloma must be ruled out. The monoclonal nature of tumor cells must also be confirmed to rule out an inflammatory process such as plasma cell granuloma (4-6).
Cerase et al., believed that if anatomically suitable, complete surgical resection followed by radiotherapy is the treatment of choice, because the tumor is very radiosensitive. Tumors at the skull base are treated by subtotal or total resection followed by radiotherapy, or irradiation alone. Systemic therapy such as chemotherapy is recommended for refractory and/or recurrent disease (2,10). Our patient was given radiotherapy and there was no tumor recurrence in the six months after diagnosis.
CoNCLuSIoN
Intracranial plasmacytoma must be suspected in all patients with a solitary dural mass, and in the differential diagnosis of meningeal tumors.
